Common Contracts

Celgene International Sàrl

August 11th, 2016

• Filed
  August 11th, 2016

Amendment #1to CLINICAL TRIAL AGREEMENTProtocol No. GED-0301-CD-001 Dodatok #1k ZMLUVE O KLINICKOM SKÚŠANÍProtokol č. GED-0301-CD-001 BY AND BETWEEN; MEDZI; Celgene Corporation, having its principal office at 86 Morris Avenue, Summit, NJ 07901, USA represented by Celgene International S.à.r.l., a limited liability company organised under the laws of Switzerland having its principal office at Route de Perreux, 2017 Boudry, Switzerland, (the “Sponsor”), PPD Investigator Services LLC, only for the purposes of signing this Agreement in the name of the Sponsor, a company organized under the laws of the State of Delaware having its principal office at 929 North Front Street, Wilmington NC 28401, USA; Celgene Corporation, ktorá má svoje sídlo na adrese 86 Morris Avenue, Summit, NJ 07901, USA, je zastúpená spoločnosťou s ručením obmedzeným Celgene International S.à.r.l., ktorá bola založená podľa zákonov Švajčiarska, a ktorá má svoje sídlo na adrese Route de Perreux, 2017 Boudry, Švajčiarsko,